Disulfiram

CHEMBL964 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
296.5 g/mol
LogP
3.9
Phase
4

A medication used as a deterrent in the treatment of alcoholism by causing an extremely unpleasant reaction (flushing, nausea, vomiting, palpitations, and hypotension) when alcohol is consumed while taking it. It works by inhibiting aldehyde dehydrogenase, causing accumulation of toxic acetaldehyde when alcohol is metabolized. It requires patient motivation and should only be used in fully abstinent patients who understand the consequences of drinking.

分子量

296.5000 g/mol

LogP

3.90

TPSA

121.00 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)C(=S)SSC(=S)N(CC)CC

InChI

InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3

Molecular Formula

C10H20N2S4

HBD / HBA

- / 4

回転可能結合数

7

重原子数

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A medication used as a deterrent in the treatment of alcoholism by causing an extremely unpleasant reaction (flushing, nausea, vomiting, palpitations, and hypotension) when alcohol is consumed while taking it. It works by inhibiting aldehyde dehydrogenase, causing accumulation of toxic acetaldehyde when alcohol is metabolized. It requires patient motivation and should only be used in fully abstinent patients who understand the consequences of drinking.

Yes, Disulfiram is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL964. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3117. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.